1. Dutta AK, Chacko A. Head mass in chronic pancreatitis: Inflammatory or malignant. World J Gastrointest Endosc. 2015 Mar 16;7(3):258-64. DOI: 10.4253/wjge.v7.i3.258
2. Manikkavasakar S, AlObaidy M, Busireddy KK, Ramalho M, Nilmini V, Alagiyawanna M, Semelka RC. Magnetic resonance imaging of pancreatitis: an update. World J Gastroenterol. 2014 Oct 28;20(40):14760- 77. DOI: 10.3748/wjg.v20.i40.14760
3. Jiang S, Li Y. A comparative analysis of CT and MRI in differentiating pancreatic cancer from mass pancreatitis. Am J Transl Res. 2021 Jun 15;13(6):6431-6438.
4. Захарова О. П., Кубышкин В. А., Кармазановский Г. Г. Протокол КТ-исследования при оценке резектабельности рака поджелудочной железы. Хирургия. Журнал им. Н. И. Пирогова. 2012;(8):44-50.
5. Chai L, Zhu N, Wang Q, Wang T, Chai W. Assessment of Malignancy Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT. Acad Radiol. 2021 May;28(5):679-686. DOI: 10.1016/j.acra.2020.03.042
6. Kamei N, Yamada Y, Hijiya N, Takaji R, Kiyonaga M, Hongo N, Ohta M, Hirashita T, Inomata M, Matsumoto S. Invasive intraductal papillary mucinous neoplasms of the pancreas: relationships between mural nodules detected on thin-section contrast-enhanced MDCT and invasive components. Abdom Radiol (NY). 2019 Sep;44(9):3139-3147. DOI: 10.1007/s00261-019-02084-2
7. Kim JH, Park SH, Yu ES, Kim MH, Kim J, Byun JH, Lee SS, Hwang HJ, Hwang JY, Lee SS, Lee MG. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010 Oct;257(1):87-96. DOI: 10.1148/radiol.10100015
8. Кармазановский Г. Г., Ахлынова О. Ю. Целесообразность и диагностическая эффективность болюсного контрастного усиления при компьютернотомографической диагностике рака поджелудочной железы. Хирургия. Журнал им. Н. И. Пирогова. 2009;(1):60-67.
9. Seo W, Kim YC, Min SJ, Lee SM. Enhancement parameters of contrast-enhanced computed tomography for pancreatic ductal adenocarcinoma: Correlation with pathologic grading. World J Gastroenterol. 2020 Jul 28;26(28):4151-4158. DOI: 10.3748/wjg.v26.i28.4151
10. Kawaji Y, Yoshikawa T, Nakagawa K, Emori T, Nuta J, Tamura T, Hatamaru K, Yamashita Y, Itonaga M, Ashida R, Terada M, Kawai M, Sonomura T, Kitano M. Computed tomography findings for predicting the future occurrence of pancreatic cancer: value of pancreatic volumetry. Int J Clin Oncol. 2021 Jul;26(7):1304-1313. DOI: 10.1007/s10147-021-01915-x
11. Ruan Z, Jiao J, Min D, Qu J, Li J, Chen J, Li Q, Wang C. Multi-modality imaging features distinguish pancreatic carcinoma from mass-forming chronic pancreatitis of the pancreatic head. Oncol Lett. 2018 Jun;15(6):9735-9744. DOI: 10.3892/ol.2018.8545
12. Wang ZQ, Li JS, Lu GM, Zhang XH, Chen ZQ, Meng K. Correlation of CT enhancement, tumor angiogenesis and pathologic grading of pancreatic carcinoma. World J Gastroenterol. 2003 Sep;9(9):2100-4. DOI: 10.3748/wjg.v9.i9.2100
13. Zaky AM, Wolfgang CL, Weiss MJ, Javed AA, Fishman EK, Zaheer A. Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning. Radiographics. 2017 Jan-Feb;37(1):93-112. DOI: 10.1148/rg.2017160054
14. Hattori Y, Gabata T, Matsui O, Mochizuki K, Kitagawa H, Kayahara M, Ohta T, Nakanuma Y. Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosis. World J Gastroenterol. 2009 Jul 7;15(25):3114-21. DOI: 10.3748/wjg.15.3114
15. Gündüz N, Buyuker F, Seneldir H, Durukan G, Alimoglu O, Kabaalioglu A. Computed Tomography-based Morphological Differences between Histologic Subtypes of Periampullary Ductal Adenocarcinoma. J Coll Physicians Surg Pak. 2021 Aug;31(8):959-964. DOI: 10.29271/jcpsp.2021.08.959
16. Chen PT, Chang D, Yen H, Liu KL, Huang SY, Roth H, Wu MS, Liao WC, Wang W. Radiomic Features at CT Can Distinguish Pancreatic Cancer from Noncancerous Pancreas. Radiol Imaging Cancer. 2021 Jul;3(4):e210010.